Efficacy and safety of reslizumab in patients with moderate to severe eosinophilic asthma.
about
Role of biologics in severe eosinophilic asthma - focus on reslizumabProfile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseasesThe efficacy and safety of reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: A systematic review and meta-analysis.Update on reslizumab for eosinophilic asthma.Benralizumab for the treatment of asthma.Anti-IgE and Biologic Approaches for the Treatment of Asthma.Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives
P2860
Q26738503-DFA93828-57C8-43C0-A447-887B8B8530E3Q26778683-D628F0CA-C967-4111-BE05-BF6B26CFA048Q30248905-234625F7-EC2F-470D-B952-2E8420117605Q38587334-16743A97-CB23-48DB-B26A-7DFB48957932Q38853525-FB51162A-65AD-466E-803F-54995C331D20Q50120034-06B2CAB9-7DFD-4BC6-958C-7B79B232FB0FQ58770201-8B60A4E5-3C54-406E-9448-9968BA488D1D
P2860
Efficacy and safety of reslizumab in patients with moderate to severe eosinophilic asthma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy and safety of reslizu ...... to severe eosinophilic asthma.
@en
type
label
Efficacy and safety of reslizu ...... to severe eosinophilic asthma.
@en
prefLabel
Efficacy and safety of reslizu ...... to severe eosinophilic asthma.
@en
P2860
P1476
Efficacy and safety of reslizumab in patients with moderate to severe eosinophilic asthma
@en
P2093
Parameswaran Nair
P2860
P304
P356
10.1586/17476348.2015.1000867
P50
P577
2015-01-12T00:00:00Z